COPPER

Search structure
Trade Names:
Synonyms:
Status: Approved
Entry Type: Small molecule
Molecule Category: Parent
UNII: 789U1901C5

Physicochemical Descriptors

Property Name Value
Molecular Formula Cu+2
Molecular Weight 63.55
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Voltage-gated ion channel Transient receptor potential channel
- 2600 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glioblastoma 2 D005909 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Alzheimer Disease 2 D000544 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Amyotrophic Lateral Sclerosis 1 D000690 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Vaginosis, Bacterial 0 D016585 ClinicalTrials

Related Entries

Salt

Side Effects from Label

Side effects Relative Frequency (%) Labels
Investigations Haemoglobin 11.9
Vascular disorders Haemorrhage 11.9
General disorders and administration site conditions Pain 11.9
Investigations Haemoglobin 9.8
Vascular disorders Haemorrhage 9.8
General disorders and administration site conditions Pain 9.8
Investigations Haemoglobin 7.0
Vascular disorders Haemorrhage 7.0
General disorders and administration site conditions Pain 7.0
Investigations Haemoglobin 3.7
Vascular disorders Haemorrhage 3.7
General disorders and administration site conditions Pain 3.7
Investigations Haemoglobin 3.5
Vascular disorders Haemorrhage 3.5
General disorders and administration site conditions Pain 3.5
Investigations Haemoglobin 3.0
Vascular disorders Haemorrhage 3.0
General disorders and administration site conditions Pain 3.0
Investigations Haemoglobin 2.7
Vascular disorders Haemorrhage 2.7
General disorders and administration site conditions Pain 2.7
Investigations Haemoglobin 2.5
Vascular disorders Haemorrhage 2.5
General disorders and administration site conditions Pain 2.5
Investigations Haemoglobin 2.2
Vascular disorders Haemorrhage 2.2
General disorders and administration site conditions Pain 2.2
Pregnancy, puerperium and perinatal conditions Pregnancy 0.7
Pregnancy, puerperium and perinatal conditions Pregnancy 0.6
Pregnancy, puerperium and perinatal conditions Pregnancy 0.4
Pregnancy, puerperium and perinatal conditions Pregnancy 0.3
Pregnancy, puerperium and perinatal conditions Pregnancy 0.2

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Product issues
32.7
Reproductive system and breast disorders
18.94
General disorders and administration site conditions
11.65
Gastrointestinal disorders
5.7
Vascular disorders
4.94
Injury, poisoning and procedural complications
4.72
Pregnancy, puerperium and perinatal conditions
4.48
Renal and urinary disorders
3.41
Musculoskeletal and connective tissue disorders
3.13

Cross References

Resources Reference
CAS NUMBER 7440-50-8
ChEMBL CHEMBL55643
FDA SRS 789U1901C5
PubChem 23978
CONTENTS